Literature DB >> 11179353

Human natural killer cells mediate killing of intracellular Mycobacterium tuberculosis H37Rv via granule-independent mechanisms.

K J Brill1, Q Li, R Larkin, D H Canaday, D R Kaplan, W H Boom, R F Silver.   

Abstract

Despite the continued importance of tuberculosis as a world-wide threat to public health, little is known about the mechanisms used by human lymphocytes to contain and kill the intracellular pathogen Mycobacterium tuberculosis. We previously described an in vitro model of infection of human monocytes (MN) with virulent M. tuberculosis strain H37Rv in which the ability of peripheral blood lymphocytes to limit intracellular growth of the organism could be measured. In the current study, we determined that lymphocyte-mediated killing of intracellular M. tuberculosis occurs within the first 24 h of coculture with infected MN. Natural killer (NK) cells isolated from both purified protein derivative (PPD)-positive and PPD-negative subjects were capable of mediating this early killing of intracellular H37Rv. NK cell-mediated killing of intracellular M. tuberculosis was not associated with the production of gamma interferon. Transferred supernatants of cocultured NK cells and M. tuberculosis-infected MN could not mediate the killing of intracellular M. tuberculosis, and Transwell studies indicated that direct cell-to-cell contact was required for NK cells to mediate the killing of the organism. Killing was not dependent upon exocytosis of NK cell cytotoxic granules. NK cells induced apoptosis of mycobacterium-infected MN, but neither killing of intracellular M. tuberculosis by NK cells nor NK cell-induced apoptosis of infected MN was inhibited by blocking the interaction of FasL and Fas. Thus, human NK cells may mediate killing of intracellular M. tuberculosis via alternative apoptotic pathways.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11179353      PMCID: PMC98082          DOI: 10.1128/IAI.69.3.1755-1765.2001

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  46 in total

1.  Differential activity of soluble versus cellular Fas ligand: regulation by an accessory molecule.

Authors:  S Sieg; D Smith; D Kaplan
Journal:  Cell Immunol       Date:  1999-08-01       Impact factor: 4.868

Review 2.  Role of natural killer cells in innate resistance to protozoan infections.

Authors:  T M Scharton-Kersten; A Sher
Journal:  Curr Opin Immunol       Date:  1997-02       Impact factor: 7.486

3.  Human natural killer cells produce abundant macrophage inflammatory protein-1 alpha in response to monocyte-derived cytokines.

Authors:  E M Bluman; K J Bartynski; B R Avalos; M A Caligiuri
Journal:  J Clin Invest       Date:  1996-06-15       Impact factor: 14.808

4.  Cloning of the cDNA for human IFN-gamma-inducing factor, expression in Escherichia coli, and studies on the biologic activities of the protein.

Authors:  S Ushio; M Namba; T Okura; K Hattori; Y Nukada; K Akita; F Tanabe; K Konishi; M Micallef; M Fujii; K Torigoe; T Tanimoto; S Fukuda; M Ikeda; H Okamura; M Kurimoto
Journal:  J Immunol       Date:  1996-06-01       Impact factor: 5.422

Review 5.  Management of health care workers after inadvertent exposure to tuberculosis: a guide for the use of preventive therapy.

Authors:  W W Stead
Journal:  Ann Intern Med       Date:  1995-06-15       Impact factor: 25.391

6.  Interleukin-12-stimulated natural killer cells can activate human macrophages to inhibit growth of Mycobacterium avium.

Authors:  L E Bermudez; M Wu; L S Young
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

Review 7.  The role of natural killer cells in innate resistance to infection.

Authors:  G J Bancroft
Journal:  Curr Opin Immunol       Date:  1993-08       Impact factor: 7.486

8.  CD4+ alpha beta T cell and gamma delta T cell responses to Mycobacterium tuberculosis. Similarities and differences in Ag recognition, cytotoxic effector function, and cytokine production.

Authors:  K Tsukaguchi; K N Balaji; W H Boom
Journal:  J Immunol       Date:  1995-02-15       Impact factor: 5.422

9.  Apoptosis, but not necrosis, of infected monocytes is coupled with killing of intracellular bacillus Calmette-Guérin.

Authors:  A Molloy; P Laochumroonvorapong; G Kaplan
Journal:  J Exp Med       Date:  1994-10-01       Impact factor: 14.307

10.  Requirement for natural killer cell-produced interferon gamma in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration.

Authors:  J S Orange; B Wang; C Terhorst; C A Biron
Journal:  J Exp Med       Date:  1995-10-01       Impact factor: 14.307

View more
  32 in total

1.  Interferon-alphabeta mediates partial control of early pulmonary Mycobacterium bovis bacillus Calmette-Guérin infection.

Authors:  John Kuchtey; Scott A Fulton; Scott M Reba; Clifford V Harding; W Henry Boom
Journal:  Immunology       Date:  2006-05       Impact factor: 7.397

2.  Antibacterial role for natural killer cells in host defense to Bacillus anthracis.

Authors:  Christine M Gonzales; Courtney B Williams; Veronica E Calderon; Matthew B Huante; Scott T Moen; Vsevolod L Popov; Wallace B Baze; Johnny W Peterson; Janice J Endsley
Journal:  Infect Immun       Date:  2011-10-17       Impact factor: 3.441

Review 3.  Striking the right immunological balance prevents progression of tuberculosis.

Authors:  Shachi Pranjal Vyas; Ritobrata Goswami
Journal:  Inflamm Res       Date:  2017-07-15       Impact factor: 4.575

4.  Changes in leucocyte and lymphocyte subsets during tuberculosis treatment; prominence of CD3dimCD56+ natural killer T cells in fast treatment responders.

Authors:  H Veenstra; R Baumann; N M Carroll; P T Lukey; M Kidd; N Beyers; C T Bolliger; P D van Helden; G Walzl
Journal:  Clin Exp Immunol       Date:  2006-08       Impact factor: 4.330

Review 5.  Early clearance of Mycobacterium tuberculosis: a new frontier in prevention.

Authors:  Ayesha J Verrall; Mihai G Netea; Bachti Alisjahbana; Philip C Hill; Reimout van Crevel
Journal:  Immunology       Date:  2014-04       Impact factor: 7.397

Review 6.  Killing Mycobacterium tuberculosis In Vitro: What Model Systems Can Teach Us.

Authors:  Tracy L Keiser; Georgiana E Purdy
Journal:  Microbiol Spectr       Date:  2017-06

7.  Control of Mycobacterium tuberculosis growth by activated natural killer cells.

Authors:  C Guerra; K Johal; D Morris; S Moreno; O Alvarado; D Gray; M Tanzil; D Pearce; V Venketaraman
Journal:  Clin Exp Immunol       Date:  2012-04       Impact factor: 4.330

8.  Human natural killer cells exhibit direct activity against Aspergillus fumigatus hyphae, but not against resting conidia.

Authors:  Stanislaw Schmidt; Lars Tramsen; Mitra Hanisch; Jean-Paul Latgé; Sabine Huenecke; Ulrike Koehl; Thomas Lehrnbecher
Journal:  J Infect Dis       Date:  2010-12-14       Impact factor: 5.226

9.  An imbalance of naive and memory/effector subsets and altered expression of CD38 on T lymphocytes in two girls with hyper-IgM syndrome.

Authors:  B T Costa-Carvalho; M A Viana; M K C Brunialti; E G Kallas; R Salomao
Journal:  Clin Exp Immunol       Date:  2004-05       Impact factor: 4.330

10.  Lack of activity of orally administered clofazimine against intracellular Mycobacterium tuberculosis in whole-blood culture.

Authors:  Ernestas Janulionis; Carolina Sofer; Ho-Yeon Song; Robert S Wallis
Journal:  Antimicrob Agents Chemother       Date:  2004-08       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.